ASBM Chairman Dr. Richard Dolinar convened a working group of Advisory Board members to discuss the elements of a physician notification policy for biosimilars that prioritizes patient safety.
Latest News
ASBM Advisory Board Members Convene on Physician Notification
Monday, June 25th, 2012